Aehr Test Systems (NASDAQ:AEHR – Get Free Report) Director Rhea Posedel sold 5,973 shares of the stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $140.00, for a total transaction of $836,220.00. Following the transaction, the director owned 381,989 shares of the company’s stock, valued at approximately $53,478,460. This represents a 1.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Aehr Test Systems Price Performance
Shares of NASDAQ AEHR opened at $134.06 on Monday. The business has a 50-day moving average of $92.83 and a 200-day moving average of $71.76. The stock has a market capitalization of $4.37 billion, a price-to-earnings ratio of -558.56 and a beta of 3.10. Aehr Test Systems has a fifty-two week low of $16.38 and a fifty-two week high of $147.40.
Key Aehr Test Systems News
Here are the key news stories impacting Aehr Test Systems this week:
- Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
- Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
- Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
- Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
- Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
- Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation
Analyst Ratings Changes
Get Our Latest Research Report on AEHR
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. Advocate Investing Services LLC bought a new stake in Aehr Test Systems in the 2nd quarter valued at $26,000. Compagnie Lombard Odier SCmA acquired a new position in shares of Aehr Test Systems in the second quarter valued at $34,000. KBC Group NV acquired a new position in shares of Aehr Test Systems in the first quarter valued at $30,000. Sunbelt Securities Inc. bought a new position in shares of Aehr Test Systems in the third quarter valued at about $27,000. Finally, Tema ETFs LLC bought a new position in shares of Aehr Test Systems in the second quarter valued at about $89,000. 69.69% of the stock is owned by institutional investors and hedge funds.
Aehr Test Systems Company Profile
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Recommended Stories
- Five stocks we like better than Aehr Test Systems
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
